# A Study to Investigate Pharmacokinetics, Safety, and Tolerability of B2227 Extended-Release Injectable Suspension and Vraylar® in Participants With Schizophrenia

> clinical trial · VERIFIED · 2026-07-23

Status: NOT_YET_RECRUITING · Sponsor: Bostal Drug Delivery Co., Ltd · Condition: Schizophrenia

- Company: Bostal Drug Delivery Co., Ltd
- Sector: Schizophrenia
- Primary source: https://clinicaltrials.gov/study/NCT07722728

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.